Products - Ear, nose and throat conditions | Topic | NICE

Showing 7 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen in people 5 to 17 years [ID6537]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
26 August 2026
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Digital technologies for the early detection and initial diagnosis of adult hearing loss (provisional title)
Status:
In development
Programme:
HealthTech guidance
Expected publication date:
TBC
Hearing aids for adults with hearing loss
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
4 February 2027
Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6440]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps [ID6379]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
9 September 2026
Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over [ID6391]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC